stockrow
Saturday 7 November 2026
Export PMN’s income statement to Excel — free account
Promis Neurosciences
- EPS
- +82.3%
- Free cash flow
- −169.5%
Quarter to June 2026, against a year earlier
4.07
0.42
+11.51%
Follow PMN
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (172.30%) | (115.73%) | (521.60%) | (355.80%) |
+8 more TTM periods Free account |
|
| (127.57%) | (100.21%) | (282.76%) | (127.40%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(85.35%) | (68.84%) | 3,230.77% | (316.67%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(4.61) | (5.45) | (16.00) | (14.10) | |
Free Cash Flow |
(42.11) | (35.58) | (28.12) | (27.55) | |
| Other line items | |||||
Cash ROIC |
(40.93%) | (28.56%) | (574.82%) | (111.91%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
1.00 | 0.88 | 0.71 | 0.94 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(4.61) | (5.45) | (16.00) | (14.10) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 26 Oct 2026